| Analysis of Differential BRAFV600E Mutational Status in High Aggressive Papillary Thyroid Microcarcinoma X Lee, M Gao, Y Ji, Y Yu, Y Feng, Y Li, Y Zhang, W Cheng, W Zhao Annals of surgical oncology 16, 240-245, 2009 | 203 | 2009 |
| Synthesis of cell-permeable stapled peptide dual inhibitors of the p53-Mdm2/Mdmx interactions via photoinduced cycloaddition MM Madden, A Muppidi, Z Li, X Li, J Chen, Q Lin Bioorganic & medicinal chemistry letters 21 (5), 1472-1475, 2011 | 130 | 2011 |
| Achieving cell penetration with distance-matching cysteine cross-linkers: a facile route to cell-permeable peptide dual inhibitors of Mdm2/Mdmx A Muppidi, Z Wang, X Li, J Chen, Q Lin Chemical communications 47 (33), 9396-9398, 2011 | 112 | 2011 |
| γ-AApeptides: design, synthesis and evaluation Y Niu, Y Hu, X Li, J Chen, J Cai New Journal of Chemistry 35 (3), 542-545, 2011 | 73 | 2011 |
| PARP-mediated PARylation of MGMT is critical to promote repair of temozolomide-induced O6-methylguanine DNA damage in glioblastoma S Wu, X Li, F Gao, JF De Groot, D Koul, WKA Yung Neuro-oncology 23 (6), 920-931, 2021 | 71 | 2021 |
| Design and synthesis of AApeptides: A new class of peptide mimics Y Hu, X Li, SM Sebti, J Chen, J Cai Bioorganic & medicinal chemistry letters 21 (5), 1469-1471, 2011 | 58 | 2011 |
| Diagnostic value of B‐RAFV600E in difficult‐to‐diagnose thyroid nodules using fine‐needle aspiration: Systematic review and meta‐analysis Y Jia, Y Yu, X Li, S Wei, X Zheng, X Yang, J Zhao, T Xia, M Gao Diagnostic Cytopathology 42 (1), 94-101, 2014 | 41 | 2014 |
| Abnormal MDMX degradation in tumor cells due to ARF deficiency X Li, D Gilkes, B Li, Q Cheng, D Pernazza, H Lawrence, N Lawrence, ... Oncogene 31 (32), 3721-3732, 2012 | 35 | 2012 |
| EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma S Wu, F Gao, S Zheng, C Zhang, E Martinez-Ledesma, R Ezhilarasan, ... Clinical Cancer Research 26 (6), 1395-1407, 2020 | 33 | 2020 |
| Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto’s thyroiditis Y Liu, X Yun, M Gao, Y Yu, X Li Clinical and Translational Oncology 17, 274-280, 2015 | 30 | 2015 |
| Hemithyroidectomy increases the risk of disease recurrence in patients with ipsilateral multifocal papillary thyroid carcinoma X Li, C Zhao, D Hu, Y Yu, J Gao, W Zhao, M Gao Oncology Letters 5 (4), 1412-1416, 2013 | 28 | 2013 |
| The promise of DNA damage response inhibitors for the treatment of glioblastoma NK Majd, TA Yap, D Koul, V Balasubramaniyan, X Li, S Khan, KS Gandy, ... Neuro-Oncology Advances 3 (1), vdab015, 2021 | 26 | 2021 |
| Conjugation of spermine enhances cellular uptake of the stapled peptide-based inhibitors of p53-Mdm2 interaction A Muppidi, X Li, J Chen, Q Lin Bioorganic & medicinal chemistry letters 21 (24), 7412-7415, 2011 | 25 | 2011 |
| 甲状腺癌的临床病理及 PET-CT 的诊断价值 高明， 李小龙， 于洋， 孙保存， 李树玲， 徐文贵 中华耳鼻咽喉头颈外科杂志 41 (6), 419-424, 2006 | 23 | 2006 |
| TIE2–FGFR1 interaction induces adaptive PI3K inhibitor resistance by upregulating Aurora A/PlK1/CDK1 signaling in glioblastoma X Li, E Martinez-Ledesma, C Zhang, F Gao, S Zheng, J Ding, S Wu, ... Cancer Research 79 (19), 5088-5101, 2019 | 21 | 2019 |
| Low expression of sodium iodide symporter expression in aggressive variants of papillary thyroid carcinoma S Wei, M Gao, C Zhao, Y Pan, H Li, J Li, X Li International Journal of Clinical Oncology 19, 800-804, 2014 | 14 | 2014 |
| Molecular aberrance in papillary thyroid microcarcinoma bearing high aggressiveness: identifying a “Tibetan Mastiff dog” from puppies D Li, M Gao, X Li, M Xing Journal of cellular biochemistry 117 (7), 1491-1496, 2016 | 13 | 2016 |
| 超声刀对比传统手术在甲状腺全切或近全切除术中安全性的 Meta 分析 赵敬柱， 高明， 于洋， 李亦工， 李小龙， 魏松锋， 刘友忠， 高健 中华耳鼻咽喉头颈外科杂志 48 (9), 752-757, 2013 | 13 | 2013 |
| 甲状腺乳头状癌合并桥本甲状腺炎的临床生物学特性分析 刘友忠， 于洋， 赵翠， 夏婷婷， 赵静， 李小龙， 魏松锋， 赵敬柱， 程文元， ... 中华普通外科杂志 28 (4), 256-258, 2013 | 13 | 2013 |
| 甲状腺乳头状微小癌的临床生物学特性研究 李小龙， 高明， 郑向前， 于洋 中国肿瘤临床 35 (23), 1325-1327, 2008 | 12 | 2008 |
Shaofang WuMD Anderson Cancer CenterVerified email at mdanderson.org
